Neurologix logo

Neurologix

Innovative therapies for brain and neurological disorders with a focus on gene therapy treatments for conditions like Parkinson's disease and epilepsy.

est. 1999

VS
uniQure logo

uniQure

Transforming the lives of patients through gene therapy

309 employees · est. 1998 · Amsterdam, The Netherlands

uniQure is the older company (1999 vs 1998).

Side-by-Side Comparison

Neurologix uniQure
Founded
1999 1998 older
Headquarters
Not tracked yet Amsterdam, The Netherlands
Employees
Not tracked yet 309
Industry
Biotechnology, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Series Unknown IPO
Total Funding
$7.00M $1.12B
Funding Rounds
1 12
Services
Not tracked yet Innovative Cures Development, Gene Therapy Research, Clinical Trials Execution, Patient Care and Support, Regulatory Compliance
Target Customers
Not tracked yet Patients and Families, Healthcare Providers, Investors, Pharmaceutical Partners, Regulatory Bodies
Taxonomy
Neurological Disorders, Gene Therapy, Parkinson's Disease, Epilepsy, Neurodegenerative Disorders, Central Nervous System, Therapeutic Treatments, Gene Transfers, Huntington's Disease, Depression, Metabolic Disorders, Fort Lee, New Jersey, Brain Disorders, Development Stage Company Gene Therapy, Genetic Diseases, Therapeutic Development, Modular Technology Platform, Huntington's Disease, AAV (Adeno-Associated Virus), ALS (Amyotrophic Lateral Sclerosis), Epilepsy Treatment, Fabry Disease, Proprietary Therapies, Partnerships In Healthcare, Innovative Medical Treatments, Curative Treatments
Website
neurologix.net uniqure.com
Neurologix logo

About Neurologix

Neurologix is a biotechnology startup founded in 1999, headquartered in Fort Lee, New Jersey. The company focuses on developing innovative therapies for brain and neurological disorders, particularly gene therapy treatments for conditions like Parkinson's disease and epilepsy. Neurologix seeks to pr...

uniQure logo

About uniQure

uniQure, founded in 1998, is at the forefront of gene therapy innovation, with a commitment to transforming the lives of patients through single treatments that hold potentially curative outcomes. The company leverages a modular and validated technology platform, which fuels its rapid advancement of...

We will tell you when either one moves

BounceWatch watches Neurologix and uniQure for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Neurologix and uniQure — by email.

Frequently Asked Questions

Neurologix — Innovative therapies for brain and neurological disorders with a focus on gene therapy treatments for conditions like Parkinson's disease and epilepsy.. uniQure — Transforming the lives of patients through gene therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Neurologix has raised $7.00M while uniQure has raised $1.12B.
Neurologix and uniQure operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Neurologix with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Neurologix on 11 Sep 2024, and uniQure on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes